Terazosin Hydrochloride (Cardinal Health)


Welcome to the PulseAid listing for the Terazosin Hydrochloride drug offered from Cardinal Health. This Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cardinal Health
NON-PROPRIETARY NAME: Terazosin Hydrochloride
SUBSTANCE NAME: TERAZOSIN HYDROCHLORIDE ANHYDROUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2009-11-02
END MARKETING DATE: 0000-00-00


Terazosin Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTerazosin Hydrochloride from Cardinal Health
LABELER NAME: Cardinal Health
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/1)
START MARKETING DATE: 2009-11-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55154-1375_536fce9d-c40a-4363-879d-fbdc40076367
PRODUCT NDC: 55154-1375
APPLICATION NUMBER: ANDA074823

Other TERAZOSIN HYDROCHLORIDE ANHYDROUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthTerazosin Hydrochloride Anhydrous
Mylan Institutional Inc.Tarazosin
Mylan Pharmaceuticals Inc.Terazosin Hydrochloride Anhydrous
PD-Rx Pharmaceuticals, Inc.Terazosin Hydrochloride Anhydrous